quinapril has been researched along with Albuminuria in 15 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 6 (40.00) | 18.2507 |
2000's | 6 (40.00) | 29.6817 |
2010's | 3 (20.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bhaheetharan, S; Ferdinand, KC; Haque, T; Khan, BV; Merchant, N; Rahman, ST; Wahi, J | 1 |
Bierhaus, A; Cooper, ME; Gray, SP; Jandeleit-Dahm, KA; Jiaze, L; Pickering, R; Soro-Paavonen, A; Thomas, MC; Tikellis, C; Tsorotes, D; Watson, AM; Wong, B | 1 |
Lim, SC; Liu, JJ; Subramaniam, T; Sum, CF | 1 |
Fujita, T; Goto, A; Onozato, ML; Tojo, A | 1 |
Chua, CL; Goh, SK; Heng, BL; Koh, AF; Lim, SC; Subramaniam, T; Sum, CF | 1 |
Barbagallo, M; Dominguez, LJ; Garcia, D; Kattah, W; Sowers, JR | 1 |
Capitán, MC; Gil, A; Lavilla, MP; Mateos, FA; Puig, JG; Ramos, TH | 1 |
Larochelle, P | 1 |
Ruilope, LM; Suarez, C | 1 |
Cozzi, MG; Giglioni, A; Guidi, E; Minetti, EE | 1 |
Asplund, K; Bystedt, T; Dahlöf, B; Jern, S; Kjellström, T; Lithell, H; Ostman, J | 1 |
Barrett, P; Connell, J; Glenn, A; Kesson, CM; McKenna, K; Smith, D; Thompson, CJ | 1 |
Ferder, LF; Inserra, F; Porter, JR; Reisin, E; Richards, RJ; Stella, I; Svec, F | 1 |
Fujita, T; Goto, A; Onozato, ML; Tojo, A; Wilcox, CS | 1 |
1 review(s) available for quinapril and Albuminuria
Article | Year |
---|---|
How should we treat hypertensive women with cardiac and renal impairment?
Topics: Adrenergic beta-Antagonists; Aged; Albuminuria; Antihypertensive Agents; Blood Pressure; Diuretics; Female; Glomerular Filtration Rate; Humans; Hypertension; Hypertrophy, Left Ventricular; Isoquinolines; Male; Nephrosclerosis; Nitrendipine; Quinapril; Renal Plasma Flow; Risk Factors; Sex Factors; Tetrahydroisoquinolines | 1997 |
7 trial(s) available for quinapril and Albuminuria
Article | Year |
---|---|
The impact of lipoic acid on endothelial function and proteinuria in quinapril-treated diabetic patients with stage I hypertension: results from the QUALITY study.
Topics: Adult; Albuminuria; Angiotensin-Converting Enzyme Inhibitors; Blood Pressure; Cross-Over Studies; Diabetes Mellitus, Type 2; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Hypertension; Male; Middle Aged; Proteinuria; Quinapril; Tetrahydroisoquinolines; Thioctic Acid | 2012 |
Elevated circulating alpha-klotho by angiotensin II receptor blocker losartan is associated with reduction of albuminuria in type 2 diabetic patients.
Topics: Albuminuria; Angiotensin II Type 1 Receptor Blockers; Diabetes Mellitus, Type 2; Drug Therapy, Combination; Female; Glucuronidase; Humans; Klotho Proteins; Losartan; Male; Middle Aged; Quinapril; Tetrahydroisoquinolines | 2014 |
Angiotensin receptor antagonist vs. angiotensin-converting enzyme inhibitor in Asian subjects with type 2 diabetes and albuminuria - a randomized crossover study.
Topics: Adult; Albuminuria; Angiotensin II Type 1 Receptor Blockers; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Asian People; Cross-Over Studies; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Female; Humans; Losartan; Male; Middle Aged; Quinapril; Singapore; Tetrahydroisoquinolines | 2007 |
Albumin excretion rate and metabolic modifications in patients with essential hypertension. Effects of two angiotensin converting enzyme inhibitors.
Topics: Adolescent; Adult; Aged; Albuminuria; Angiotensin-Converting Enzyme Inhibitors; Blood Pressure; Calcium; Captopril; Double-Blind Method; Female; Heart Rate; Humans; Hypertension; Isoquinolines; Lipids; Male; Middle Aged; Quinapril; Single-Blind Method; Tetrahydroisoquinolines | 1994 |
Effect of quinapril on the albumin excretion rate in patients with mild to moderate essential hypertension. Multicenter Study Group.
Topics: Albuminuria; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Blood Pressure; Diuretics; Female; Heart Rate; Humans; Hydrochlorothiazide; Hypertension; Isoquinolines; Male; Middle Aged; Quinapril; Sodium Chloride Symporter Inhibitors; Tetrahydroisoquinolines | 1996 |
Comparison of effects of quinapril and metoprolol on glycaemic control, serum lipids, blood pressure, albuminuria and quality of life in non-insulin-dependent diabetes mellitus patients with hypertension. Swedish Quinapril Group.
Topics: Adrenergic beta-Antagonists; Aged; Albuminuria; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Blood Glucose; Blood Pressure; C-Peptide; Diabetes Mellitus, Type 2; Double-Blind Method; Female; Glucose Tolerance Test; Hemoglobin A; Humans; Hypertension; Insulin; Isoquinolines; Lipids; Male; Metoprolol; Middle Aged; Quality of Life; Quinapril; Sweden; Tetrahydroisoquinolines | 1998 |
Angiotensin-converting enzyme inhibition by quinapril blocks the albuminuric effect of atrial natriuretic peptide in Type 1 diabetes and microalbuminuria.
Topics: Albuminuria; Angiotensin-Converting Enzyme Inhibitors; Atrial Natriuretic Factor; Creatinine; Diabetes Mellitus, Type 1; Humans; Insulin; Isoquinolines; Kinetics; Male; Placebos; Quinapril; Tetrahydroisoquinolines | 2000 |
7 other study(ies) available for quinapril and Albuminuria
Article | Year |
---|---|
Adolescent type 1 Diabetes Cardio-renal Intervention Trial (AdDIT).
Topics: Adolescent; Albuminuria; Angiotensin-Converting Enzyme Inhibitors; Area Under Curve; Atorvastatin; Biomarkers; Cardiomyopathies; Diabetes Mellitus, Type 1; Diabetic Nephropathies; Double-Blind Method; Drug Therapy, Combination; Dyslipidemias; Female; Follow-Up Studies; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Multicenter Studies as Topic; Puberty; Pyrroles; Quinapril; Randomized Controlled Trials as Topic; Research Design; Risk; Tetrahydroisoquinolines | 2009 |
Alagebrium reduces glomerular fibrogenesis and inflammation beyond preventing RAGE activation in diabetic apolipoprotein E knockout mice.
Topics: Albuminuria; Animals; Apolipoproteins E; Diabetes Mellitus, Experimental; Fibrosis; Glomerular Mesangium; Glomerulonephritis; Glycation End Products, Advanced; Male; Mice; Mice, Knockout; Nephritis; Oxidative Stress; Quinapril; Receptor for Advanced Glycation End Products; Receptors, Immunologic; Tetrahydroisoquinolines; Thiazoles | 2012 |
Effect of combination therapy with dipyridamole and quinapril in diabetic nephropathy.
Topics: Albuminuria; Angiotensin-Converting Enzyme Inhibitors; Animals; Blood Glucose; Blotting, Western; Creatinine; Cyclic GMP; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Dipyridamole; Drug Therapy, Combination; Female; Immunohistochemistry; Isoquinolines; Kidney; Lipid Peroxides; NADH, NADPH Oxidoreductases; NADPH Oxidases; Nitric Oxide Synthase; Nitric Oxide Synthase Type I; Phosphodiesterase Inhibitors; Phosphoproteins; Quinapril; Random Allocation; Rats; Rats, Sprague-Dawley; Tetrahydroisoquinolines | 2003 |
Quinapril reduces microalbuminuria in essential hypertensive and in diabetic hypertensive subjects.
Topics: Albuminuria; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Blood Glucose; Blood Pressure; Diabetes Mellitus, Type 2; Female; Glucose Tolerance Test; Humans; Hypertension; Insulin; Isoquinolines; Male; Middle Aged; Quinapril; Tetrahydroisoquinolines | 1995 |
Which urinary proteins are decreased after angiotensin converting--enzyme inhibition?
Topics: Albuminuria; Angiotensin-Converting Enzyme Inhibitors; Blood Glucose; Blood Pressure; Body Weight; Creatinine; Electrolytes; Electrophoresis, Polyacrylamide Gel; Female; Heart Rate; Humans; Hypertension; Isoquinolines; Male; Mucoproteins; Peptidyl-Dipeptidase A; Quinapril; Tetrahydroisoquinolines; Uric Acid; Uromodulin | 1998 |
Effects of dehydroepiandrosterone and quinapril on nephropathy in obese Zucker rats.
Topics: Actins; Albuminuria; Angiotensin-Converting Enzyme Inhibitors; Animals; Creatinine; Dehydroepiandrosterone; Diuresis; Isoquinolines; Kidney; Kidney Diseases; Muscle, Smooth; Natriuresis; Obesity; Organ Size; Proteinuria; Quinapril; Rats; Rats, Zucker; Tetrahydroisoquinolines; Thinness; Tissue Distribution | 2001 |
Oxidative stress and nitric oxide synthase in rat diabetic nephropathy: effects of ACEI and ARB.
Topics: Albuminuria; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Benzimidazoles; Biphenyl Compounds; Diabetic Nephropathies; Female; Hydrogen Peroxide; Isoquinolines; Kidney; Lipid Peroxidation; NADPH Oxidases; Nitric Oxide; Nitric Oxide Synthase; Nitric Oxide Synthase Type I; Nitric Oxide Synthase Type III; Oxidative Stress; Phosphoproteins; Proteinuria; Quinapril; Rats; Rats, Sprague-Dawley; Reactive Oxygen Species; Receptor, Angiotensin, Type 1; Receptors, Angiotensin; Superoxides; Tetrahydroisoquinolines; Tetrazoles; Tyrosine | 2002 |